IRON Financial LLC Purchases New Position in Cardinal Health, Inc. $CAH

IRON Financial LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAH) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,172 shares of the company’s stock, valued at approximately $670,000.

Several other institutional investors and hedge funds have also bought and sold shares of CAH. Norges Bank bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $790,344,000. Wellington Management Group LLP raised its holdings in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Holocene Advisors LP raised its holdings in Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after purchasing an additional 1,128,358 shares in the last quarter. Marshall Wace LLP lifted its position in Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after buying an additional 884,648 shares during the period. Finally, Barclays PLC lifted its position in Cardinal Health by 109.3% during the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after buying an additional 827,446 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.1%

Shares of CAH opened at $238.79 on Friday. The company has a market capitalization of $55.93 billion, a P/E ratio of 36.51, a price-to-earnings-growth ratio of 1.17 and a beta of 0.49. The firm has a 50 day moving average of $208.99 and a 200 day moving average of $211.70. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $240.93.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the prior year, the firm posted $2.35 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Morgan Stanley increased their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. TD Cowen boosted their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Citigroup reissued a “buy” rating on shares of Cardinal Health in a research report on Thursday. JPMorgan Chase & Co. cut their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Finally, Robert W. Baird set a $248.00 price target on Cardinal Health in a report on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $247.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.